Zurcher Kantonalbank Zurich Cantonalbank Has $2.65 Million Stock Position in Sabra Health Care REIT, Inc. (NASDAQ:SBRA)

Zurcher Kantonalbank Zurich Cantonalbank raised its holdings in Sabra Health Care REIT, Inc. (NASDAQ:SBRA) by 50.7% during the fourth quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 153,261 shares of the real estate investment trust’s stock after buying an additional 51,595 shares during the quarter. Zurcher Kantonalbank Zurich Cantonalbank owned 0.06% of Sabra Health Care REIT worth $2,654,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors have also recently added to or reduced their stakes in the business. AlphaQuest LLC grew its holdings in Sabra Health Care REIT by 2,375.2% in the 4th quarter. AlphaQuest LLC now owns 35,371 shares of the real estate investment trust’s stock valued at $613,000 after buying an additional 33,942 shares during the last quarter. Edgestream Partners L.P. acquired a new stake in Sabra Health Care REIT in the 4th quarter valued at approximately $2,593,000. Jackson Creek Investment Advisors LLC grew its holdings in Sabra Health Care REIT by 3.8% in the 4th quarter. Jackson Creek Investment Advisors LLC now owns 96,914 shares of the real estate investment trust’s stock valued at $1,679,000 after buying an additional 3,576 shares during the last quarter. Inceptionr LLC grew its holdings in Sabra Health Care REIT by 15.3% in the 4th quarter. Inceptionr LLC now owns 30,210 shares of the real estate investment trust’s stock valued at $523,000 after buying an additional 4,011 shares during the last quarter. Finally, Raymond James Financial Inc. acquired a new stake in Sabra Health Care REIT in the 4th quarter valued at approximately $887,000. Institutional investors and hedge funds own 99.40% of the company’s stock.

Sabra Health Care REIT Price Performance

Sabra Health Care REIT stock opened at $17.30 on Friday. The company has a debt-to-equity ratio of 0.88, a current ratio of 4.32 and a quick ratio of 4.16. The company has a market capitalization of $4.12 billion, a PE ratio of 32.64, a price-to-earnings-growth ratio of 1.97 and a beta of 1.27. Sabra Health Care REIT, Inc. has a one year low of $13.31 and a one year high of $20.03. The business has a 50 day simple moving average of $16.72 and a 200 day simple moving average of $17.66.

Sabra Health Care REIT (NASDAQ:SBRA) last posted its earnings results on Wednesday, February 19th. The real estate investment trust reported $0.36 EPS for the quarter, hitting the consensus estimate of $0.36. The business had revenue of $182.35 million during the quarter, compared to the consensus estimate of $178.01 million. Sabra Health Care REIT had a return on equity of 4.60% and a net margin of 18.02%. On average, sell-side analysts forecast that Sabra Health Care REIT, Inc. will post 1.45 EPS for the current fiscal year.

Sabra Health Care REIT Dividend Announcement

The business also recently announced a quarterly dividend, which was paid on Friday, February 28th. Investors of record on Friday, February 14th were given a dividend of $0.30 per share. The ex-dividend date was Friday, February 14th. This represents a $1.20 annualized dividend and a dividend yield of 6.94%. Sabra Health Care REIT’s dividend payout ratio (DPR) is presently 226.42%.

Wall Street Analysts Forecast Growth

A number of analysts have issued reports on the company. Mizuho reaffirmed a “neutral” rating and issued a $20.00 target price on shares of Sabra Health Care REIT in a report on Thursday, December 5th. Citizens Jmp raised Sabra Health Care REIT from a “hold” rating to a “strong-buy” rating in a report on Tuesday, January 7th. JMP Securities raised Sabra Health Care REIT from a “market perform” rating to an “outperform” rating and set a $20.00 price objective on the stock in a report on Tuesday, January 7th. Finally, Truist Financial lowered Sabra Health Care REIT from a “buy” rating to a “hold” rating and decreased their price objective for the stock from $18.00 to $17.00 in a report on Friday, January 17th. Three research analysts have rated the stock with a hold rating, three have issued a buy rating and one has given a strong buy rating to the stock. According to MarketBeat.com, Sabra Health Care REIT presently has a consensus rating of “Moderate Buy” and a consensus price target of $19.17.

About Sabra Health Care REIT

Sabra Health Care REIT, Inc engages in the business of acquiring, financing, and owning real estate property. The company was founded on May 10, 2010 and is headquartered in Tustin, CA.